会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 62. 发明授权
    • Reading an external memory device to determine its interface characteristics for configuring a programmable logic device
    • 读取外部存储器件以确定其用于配置可编程逻辑器件的接口特性
    • US07868654B1
    • 2011-01-11
    • US12465444
    • 2009-05-13
    • Wei HanWarren JuenemannMose Wahlstrom
    • Wei HanWarren JuenemannMose Wahlstrom
    • H03K19/173
    • H03K19/17748H03K19/17744
    • Various techniques are provided for determining interface characteristics of external devices. In one example, a method of configuring a programmable logic device (PLD) with configuration data stored in one or more external memory devices includes reading by the PLD an interface setup command in a bitstream from an external memory device through a configuration port of the PLD while operating the configuration port in accordance with a first set of interface characteristics. The method also includes adjusting by the PLD the configuration port to operate in accordance with a second set of interface characteristics identified by the interface setup command. The method also includes reading by the PLD configuration data in the bitstream from the external memory device through the configuration port while operating the configuration port in accordance with the second set of interface characteristics. The method also includes programming a configuration memory of the PLD with the configuration data.
    • 提供了各种用于确定外部设备的接口特性的技术。 在一个示例中,配置具有存储在一个或多个外部存储器件中的配置数据的可编程逻辑器件(PLD)的方法包括由PLD通过PLD的配置端口从外部存储器件读取位流中的接口设置命令 同时根据第一组接口特性来操作配置端口。 该方法还包括由PLD调整配置端口以根据由接口设置命令标识的第二组接口特性进行操作。 该方法还包括通过配置端口从外部存储器件通过PLD配置数据读取数据,同时根据第二组接口特性来操作配置端口。 该方法还包括使用配置数据对PLD的配置存储器进行编程。
    • 64. 发明申请
    • THIOPHENE DERIVATIVES AS FACTOR XIA INHIBITORS
    • THIOPHENE DERIVATIVES作为因子XIA抑制剂
    • US20090253766A1
    • 2009-10-08
    • US12097068
    • 2006-12-13
    • Wei Han
    • Wei Han
    • A61K31/416C07D333/22A61K31/381C07D231/56A61P29/00A61P7/00A61P9/00
    • C07D333/24C07D333/28C07D409/04
    • The present invention provides compounds of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, L1, R3, and R11 are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    • 本发明提供式(I)的化合物或其立体异构体,互变异构体,药学上可接受的盐,溶剂合物或前药,其中变量A,L1,R3和R11如本文所定义。 式(I)的化合物可用作凝血级联和/或接触激活系统的丝氨酸蛋白酶的选择性抑制剂; 例如凝血酶,因子Xa,因子XIa,因子IXa,因子VIIa和/或血浆激肽释放酶。 特别地,它涉及作为选择性因子XIa抑制剂的化合物。 本发明还涉及包含这些化合物的药物组合物和使用其制备血栓栓塞和/或炎症性疾病的方法。